The entire market of medical devices has grown more
significantly around the globe with the huge investment by the existing key
players and effective developments in the technology. However, the significant
developments in the blood glucose monitoring systems also lead the market
growth effectively. The blood glucose monitoring is an essential part of the
standard diabetes care, and it is very helpful in holding the glucose levels in
a human body with diabetes and impaired glucose
tolerance. The occurrence of diabetes is growing across the globe, and
approximately 90% of the patients have type 2 diabetes mellitus with around
one-fifth of the people undergoing insulin treatment. The key players of this
market are dominating the handsome amount of share by developing their
techniques of doing work which further proved to be efficient for leading the
fastest market growth during the forecasted period more significantly.
According to the report analysis, ‘Global
Blood Glucose Monitoring Systems Market 2018-2024’ it states that there are several key players
which are presently functioning in this market more significantly for
accounting the highest market share across the globe with the implementation of
effective technologies after knowing the coming trends includes Medtronic plc,
Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC
Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia
Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy
Diabetes Care LLC, and niche players. The market has an enormous number of
medium and small players that offer efficient products and has enormous growth
opportunity, especially in the developing countries. The key market players are
taking benefit of product approvals and new product promotions, making their
strategies to increase the market share.
Although, the Global Blood Glucose Monitoring Systems
market is expected to observe an effective CAGR of 6.7% during the forecast
period of 2018-2024. Whereas, the market of blood glucose monitoring
system is segmented into four segments which majorly includes products,
end-users, regions and applications. On the basis of region, the market is
further divided into North America, Europe, Asia Pacific, and Rest of the World
(RoW). North America is the foremost shareholder in the global blood glucose
monitoring systems market, followed by Europe. The Asia Pacific region is
predictable to rise at a high CAGR during the forecast period because of an
upsurge in access to health care services, significant growing patient pool,
increasing consciousness among patients, and growing healthcare
expenditure. Not only has this, the increasing collaboration and funding
to improve innovative devices and growing awareness among the patients are
delivering an opportunity for the market growth.
Whereas, on the basis of end-users, the market is
further segmented into hospitals, homecare, private clinics, and others. Among
different end-users, homecare attained a proficient market share and is
anticipated to remain the same during the forecast period. Therefore, in the
near future, it is expected that the market of blood glucose monitoring systems
will increase more significantly over the recent few years.
To know more, click on the link
below:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
